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Recent studies have reported that iPSCs are capable
of differentiating into various functional cell types,
including neurons, cardiomyocytes and hematopoietic
cells (Karumbayaram et al., 2009; Raya et al., 2009; Zwi
et al., 2009). Transplantation of neurospheres derived
from murine iPS cell clones into the injured spinal cord was
found to be able to promote functional recovery without
tumor formation (Tsuji et al., 2010). Grafted dopaminer-
gic neurons derived from iPSCs could alleviate the disease
phenotype in a rat model of Parkinson's disease (Wernig et
al., 2008). These studies suggest that iPSCs could be used
for regenerative and therapeutic purposes. One of major
concerns about the therapeutic use of iPSCs is the low
efficiency and high variability in their neural differentia-
tion. In the present study, we proposed a novel approach
which drives mouse iPSCs to efficiently differentiate into
neural cells and searched for critical molecules which are
responsible for the neural differentiation and patterning
of iPSCs.Methods
Cell culture
Two mouse ES cell lines (passages 20–25) and 8 mouse iPS
cell lines (passages 15–20) were used in the study. Both
mouse ES cell lines (R1 and ES-C57BL/6) were from
American Type Culture Collection (ATCC); five mouse iPS
cell lines (O4-1; S5-3C5; IP14D-101; 3F-CB9; MEC-1) were
from previously reported studies (Chen et al., 2010, 2011;
Li et al., 2010; Liao et al., 2011; Zhao et al., 2009) and 3
mouse iPS cell lines (MEF-4,TTF-1 and MEF-p) were firstly
used in the present study (Table S1). All the cells were
maintained on mitomycin-treated MEF feeder cell layers
and cultured in KSR medium consisting of DMEM Dulbecco's
Modified Eagle's Medium (DMEM; GIBCO, Invitrogen),
supplemented with 20% knock-out serum replacement
(KSR, GIBCO, Invitrogen), 2 mM L-glutamine, 0.1 mM non-
essential amino acids, 0.1 mM β-mercaptoethanol, and
1000 U/ml leukemia inhibitory factor (LIF, Chemicon
International) with the culture medium renewed every
day.
Neural induction
Neural differentiation in adherent monoculture
Neural differentiation was firstly induced in an adherent
monoculture method as described previously with minor
modification (Ying et al., 2003). Briefly, after initial
expansion on inactivated MEF feeder cells, iPS and ES cell
colonies were passaged up to 3 times without feeder cellson gelatin-coated dishes to eliminate contaminating MEFs.
Undifferentiated cells were subsequently dissociated into
single cells and plated onto gelatin-coated tissue culture
plastic at a density of 0.5–1.0×104/cm2 in N2B27 medium
consisting of a 1:1 mixture of DMEM/F12 supplemented
with 1% N2 (Invitrogen) and Neurobasal medium supple-
mented with 2% B27 (Invitrogen). The cells were cul-
tured in the medium which was renewed daily for up to 8–
10 days.
Neural differentiation using EB formation methods
EB methods are widely employed to drive pluripotent cells to
differentiate into various neural phenotypes. Here, we exam-
ined the differentiation potency of mouse iPSCs and ESCs using
EBs methods which were formed in three different ways.
EB formation in single-cell suspensions. Using single-cell
suspensions to form EBs is a widely used method to induce
mouse iPSCs and ESCs to differentiate into neural cells
(Miura et al., 2009; Wichterle et al., 2002). We dissoci-
ated iPSCs or ESCs into single cells after removal of feeder
cells. They were then grown at 0.5–1×105 cells/ml in
aggregate cultures for 2 days in DFK10 medium to form
EBs. DFK10 medium consisted of DMEM/F12 (invitrogen)
supplemented with 10% Knock-out serum replacement,
2.4% N2 (GIBCO), 4500 mg/l Glucose, 2 mM L-glutamine,
1 u/μl Heparin (Sigma), and 0.1 mM β-mercaptoethanol.
The formed EBs were further proceeded to inducemotoneurons
or NPC differentiation.
For motoneuron differentiation, the formed EBs in DFK10
medium were supplemented with retinoic acid (RA, 0.1 μM;
Sigma) and sonic hedgehog (SHH, 200 ng/ml, R&D Systems)
and cultured for additional 5 days. The RA and SHH-treated
EBs were then plated on laminin-coated coverslips and sub-
sequently supplementedwith 10 ng/ml BDNF, 10 ng/ml GDNF,
10 ng/ml CNTF, and 10 ng/ml IGF (all from Peprotech) to aid
in neuronal survival.
For NSC differentiation, the formed EBs were treated with
RA (0.1 μM) for additional 4 days. RA-treated EBs were then
collected, dissociated to single cells by accutase and cultured at
0.5–1×105 cells/ml in non-adherent culture dishes in N2B27
medium supplemented with 20 ng/ml bFGF (R&D Systems) and
20 ng/ml EGF (Sigma). Primary neurospheres were formed after
5–7 days culture.
For dopaminergic neuron differentiation, the EBs were
formed in DFK10 medium for 4 days and then plated on laminin
coated plate. After 24 h of culture, DFK10 medium was
replaced by DFK10 supplemented with 1% Insulin/Transferrin/
Selenium/Fibronectin (ITSFn, GIBCO)medium. After 6–10 days,
neural tube-like rosettes were selected and dissociated by
0.05% trypsin/EDTA, and plated on laminin-coated coverslips
in 24-well plate in N2 medium supplemented with 10 ng/ml
bFGF, 200 ng/ml SHH and 100 ng/ml FGF8b (R&D Systems).
After 5 days, the culture medium was changed to N2 medium
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10 ng/ml GDNF and cultured for 5–10 days.
EB formation in “hanging drops”. To initiate EB forma-
tion, “hanging drops” composed of 1000 cells in 20 μl of
DFK10 medium were generated (day 0 of differentiation).
After 2 days (day 2 of differentiation), the EBs were
transferred into 25 cm2 flasks and cultivated for further
differentiation into motoneurons, NSCs or dopaminergic
neurons as described above.
EB formation in whole cell clones. After 3–4 days culture
on MEF feeders in KSR medium, the whole iPSC or ESC clones
were directly isolated with a fire polished glass pipette with a
curved and fine tip and grew in DFK10 medium for 2 days to
generate EBs. After 2 days, the EBs were transferred into
25 cm2 flasks and cultivated for further differentiation into
motoneurons, NSCs or dopaminergic neurons as described
above.
In vitro immunocytochemistry study and
quantification
Cells were fixed in 4% p-formaldehyde dissolved in 0.1 M
phosphate buffer (PB) for 20 min. After several washes with
0.01 M phosphate-buffered saline (PBS), the cultures were
incubated with the primary antibodies in PBS plus 1% BSA, 10%
normal goat serum, and 0.3% Triton X-100 over night at 4 °C.
The following primary antibodies were used to stain the cells:
monoclonal anti-Nestin (1: 500; Sigma) for NSCs; polyclonal
anti-MAP2 (1: 500; Chemicon) for neurons; monoclonal anti-
Islet1/2 (1: 500; Developmental Studies Hybridoma Bank,
DSHB) for motoneurons; monoclonal anti-TH (1:500; Sigma) for
dopaminergic neurons. Primary antibodies were visualized
with species-specific secondary antibody conjugated to the
fluorescent labels Alexa 568 or 488 (1: 400; Molecular Probe,
Eugene, OR, USA). Cells were mounted in anti-fade medium
containing 4′,6-diamidino-2-phenylindole (Sigma) to counter-
stain nuclei. To quantify neuronal population, 8–9 represen-
tative fields per well were randomly selected and five wells
per experiment were imaged. Cells were counted on images
imported and processed using a semi-automatic stereology
system with stereo investigator (MicroBrightField, Williston,
VT). Results are mean±SEM of data from five experiments
unless stated otherwise in legends.
Fluorescence-activated cell sorting
To quantify the efficiency of NSC differentiation of iPS cells by
EB methods in 3 different manners, primary neurospheres were
dissociated into single cells and fixed directly to perform
fluorescence-activated cell sorting (FACS) analysis. Cells incu-
bated with PerCP-Cy5.5-conjugated Nestin (BD Pharmingen)
were analyzed using a BectonDickinson FACSCalibur instrument
and CellQuest Pro software (BD Biosciences, San Diego).
Whole-cell patch-clamp recordings
Whole-cell patch-clamp recording techniques were used to
study the intrinsic properties of mouse iPSC-derived moto-
neurons in culture. Resting potentials were maintained atabout −65 mV. Whole-cell patch-clamp techniques were
amplified and filtered using an Axopatch 200B amplifier
(Molecular Devices, Sunnyvale, CA). Graded current in-
jections used durations of 300 ms (in steps of 5 pA). Signals
were sampled at 10 kHz using a Digidata 1440A analog to
digital converter and acquired and stored on a computer
hard drive using pClamp10 software. Data were analyzed
using pClamp10 (Clampfit).
In vivo transplantation
In order to track transplanted iPS-derivatives in vivo, the
selected iPS cell line (MEF-p) was transfected with len-
tiviral vectors (pRloxp) containing RFP (dtomato) gene.
Successful RFP-labeled MEF-p cells were induced into
motoneurons and dopaminergic neurons using the whole
cell-clone EB method. Totally 16 adult male C57BL/6 mice
were used in the transplantation study and were divided
evenly into 2 groups: one group received iPSC-derived
motoneuron transplantation into the transected sciatic
nerve and the other group received iPSC-derived dopami-
nergic neuron transplantation into the striatum of brain.
For iPSC-derived motoneuron transplantation, the EBs
were gently dissociated into single cells by accutase
after 5 days of treatment with 0.1 μM RA and 200 ng/ml
SHH and resuspended in N2 medium supplemented with
10 μg/ml BDNF, 10 μg/ml GDNF, 10 μg/ml CNTF, and
10 μg/ml IGF at a concentration of 1.0×105 cells/μl and
placed on ice for the duration of the grafting session.
After the right sciatic nerve was isolated and transected,
1 μl of cell suspension was slowly injected into the nerve
through a Hamilton syringe with the sharpened tip. For iPSC-
derived dopaminergic neuron transplantation, cells were
gently dissociated by accutase and resuspended in themedium
supplemented with 10 μg/ml BDNF, 10 μg/ml GDNF and
10 μg/ml CNTF at a concentration of 1.0×105 cells/μl after
18 days of differentiation in vitro. The cells were injected
at the following coordinates from Bregma: anteroposterior,
+0.4; mediolateral, +1.8; and dorsoventral, −3.0. One
microliter of cell suspension was slowly injected into
the brain. A 2-min waiting period allowed the cells to
settle before the needle was removed. The animals were
kept warm and allowed to recover from anesthesia before
returning to their cages. Cyclosporine A (Sandimmune;
Sandoz) was injected intraperitoneally to suppress immune
rejection. All the animals were allowed to survive for
8 weeks.
Tissue processing
At the end of the animal survival period, the animals were
anesthetized and perfused intracardially with 0.01 M PBS,
pH 7.4, followed by 200–300 ml of fixative solution con-
taining 4% p-formaldehyde in 0.1 M PB, pH 7.4. The brain
and sciatic nerve were harvested and post-fixed in fresh
fixative solution overnight and subsequently placed in
30% sucrose–0.1 M PB at 4 °C for 2–3 days. The samples
were then cut into 30 μm cross sections on a microtome
(American Optical Company, Buffalo, NY, USA). The serial
sections were collected in 0.01 M PBS and kept at 4 °C for
further study.
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Brain tissue sections with the injection site, defined by
RFP-positive cell region, were selected for immunostaining.
Selected sections were washed in 0.01 M PBS, blocked in 10%
goat serum for 1 h, and incubated with primary antibodies at
4 °C overnight. Neurons were detected dopaminergic neurons
were identified using monoclonal anti-TH (1:500; Sigma).
Species-specific fluorescence-conjugated secondary antibodies
conjugated to Alexa 488 (1:400; Molecular Probes) were applied
for 2 h at 20 °C. Sections were then counterstained with
4′,6-diamidino-2-phenylindole to stain nuclei, and coverslipped
with anti-fade mounting media (FluorSave; Calbiochem, San
Diego, CA, USA). A Leica TCS SP2 Spectral confocal microscope
was used for all immunoflorescence studies.
Whole-genome expression analysis
Total RNAs were extracted from the MEF-4 and MEF-p cells in
day 2 of neural differentiation by EB methods in 3 different
manners, and quantified by the NanoDrop ND-1000 and RNA
integrity was assessed by standard denaturing agarose gel
electrophoresis. About 5 μg total RNA was used for the reverse
transcription with Invitrogen Superscript ds-cDNA synthesis kit.
Labeled cDNA was synthesized by in vitro transcription using
NimbleGen one-color DNA labeling kit. Array hybridization using
the NimbleGen Hybridization System and followed by washing
with the NimbleGen wash buffer kit. Arrays were scanned with
the Axon GenePix 4000B microarray scanner. Data were
analyzed with NimbleScan software (version 2.5).
Overexpression and shRNA knockdown
cDNAs of candidate factors were cloned into pRLoxP-Puro
retrovirus vectors. pReceiver-Lv156R-Nnat and pReceiver-
Lv156R-Ptn were purchased from GeneCopoeia. pLKO.1-TRC
Cloning Vector (sigma) containing shRNA sequences for Cdh2
was made in our lab. The target sequence for Cdh2-shRNA
was GCCATGACTTTCTACGGAGAA, and GAACAGTTTCACCT
GATATTC, namely shCdh2#1, and shCdh2#2 respectively.
To produce infectious lentiviral particles, HEK293T cells cul-
tured on 10 cm dishes were transfected with target plasmids
togetherwith the packaging plasmids psPAX2 and pMD2.G. Viral
supernatants were harvested after 2 day transfection; these
supernatants were administered in ES and iPS culture. After
infection, cells were selected in puromycin for 3 days.
Quantitative RT-PCR (qPCR)
Total RNAs were extracted using TRIzol (Invitrogen). Quantita-
tive real time RT-PCR (qPCR) was performed using a Thermal
Cycler DiceTM Real Time System and SYBR Premix EX TaqTM
(Takara). β-Actin was used for qPCR normalization, and all
items were measured in triplicate. All primer sequences are
listed in Table S2.
Statistics
The differences between multiple group comparisons were
made by one-way ANOVA and followed by Fisher's post-hoc test.Data are presented as mean±SEM. Significance levels were set
to pb0.05 for all comparisons.
Results
Mouse iPSCs exhibited low efficiency in neural
differentiation compared to mouse ESCs
In adherent monoculture, mouse ESCs can efficiently develop
into neural stem cells (NSCs) in N2B27 medium (Ying et al.,
2003). It is an easy way to drive pluripotent cell differentiation
due to no need for multicellular aggregation or coculture
induction. In the present study, we first used this method to
examine the neural differentiation potency of mouse ESCs and
iPSCs. Two mouse ES cell lines and 8 mouse iPS cell lines were
used in the study (Table S1). Karyotype analyses were
performed on all these cell lines prior to neural induction and
all these cell lines including mouse ES cell lines and mouse iPS
cell lines showed a normal karyotype (data not shown). After
plating and culturing dissociatedmouse ESCs (R1 and ES-C57BL/
6) in N2B27 medium for up to 8–10 days, abundant rosette-like
structures with positive Nestin staining were formed (Figs. 1A
and B). To our surprise, however, all iPS cell lines tested failed
to form evident neural rosettes and showed very limited ability
to give rise to NSCs (Figs. 1C and D), regardless of if the iPSCs
were from adult or fetal cells, if the iPSCs were generated by
transfection with 1, 3 or 4 genes, if the iPSCs were established
with or without transgene integration (transgenic vs. plasmid-
induced), or even if the iPSCs could successfully generate viable
mice through tetraploid complementation (IP14D-101). Our
results are inconsistent with a previous study that reported that
mouse iPSCs could efficiently differentiate into a monolayer of
self-renewing NSCs in the adherent approach (Onorati et al.,
2010). The true pluripotency of mouse iPSCs has been proven by
a number of studies (Boland et al., 2009; Zhao et al., 2009) and
they are supposed to behave similarly as ESCs in various aspects
such as differentiation potentials. It is a surprising finding that
mouse iPSCs in our study failed to efficiently differentiate into
neural cells in the adherent approach as mouse ESCs did even
we followed the protocol in the study which reported successful
differentiation(Onorati et al., 2010). Although the exact rea-
sons underlying the difference in our study and Onorati's study
remain to be further explored, the results of our study suggest
that mouse iPSCs cannot differentiate into neural cells as easily
and efficiently as mouse ESCs do in the adherent approach.
We then employed EB methods to induce mouse iPSC neural
differentiation. Using single-cell suspension to form EBs has
been widely used in many laboratories to drive mouse plu-
ripotent cells to differentiate (Miles et al., 2004; Miura et al.,
2009; Okada et al., 2008;Wichterle et al., 2002).When exposed
to RA and SHH, mouse ESCs in EBs can be patterned into
motoneurons (Miles et al., 2004; Wichterle et al., 2002). We
followed this protocol to examine the potency ofmouse iPSCs to
be patterned into specific neuronal phenotypes. We found that
R1 and ES-C57BL/6 could efficiently generate MAP2-positive
cells (64% for R1 and 60% for ES-C57BL/6 respectively) and
Islet1/2-positive cells (61% for R1 and 58% for ES-C57BL/6
respectively) after 5 days of treatment with RA and SHH
(Figs. 2A and a). In contrast, all iPS cell lines exhibited very
low efficiency in neuronal differentiation using the single-cell
suspension derived EB method (Figs. 2B, b, C and D). The
Figure 1 Marked difference in neural differentiation between mouse ESCs and iPSCs in adherent monoculture. Mouse ESCs
efficiently differentiate into NPCs in N2B27 medium, whereas mouse iPSCs show very limited ability to give rise to neural cells in
adherent monoculture. (A): Confocal images of R1 differentiation into Nestin-positive NPCs. (B): Confocal images of ES-C57BL/6
differentiation into Nestin-positive NPCs. (C): Confocal images of MEF-p differentiation into Nestin-positive NPCs. (D): Confocal
images of MEC-1 differentiation into Nestin-positive NPCs. Scale bar: 150 μm.
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differentiation to 24% in MEF-p differentiation (Fig. 2C)
and the percentage of Islet1/2-positive cells ranged from
4% in IP14D-101 differentiation to 11% in MEF-p differen-
tiation (Fig. 2D). All of them displayed a significantly lower
neuronal differentiation efficiency compared to mouse
ESCs (Figs. 2C and D; Pb0.001). These findings suggest that
mouse iPSCs are less potential in neural differentiation
compared to mouse ESCs.The whole cell clone-derived EB method significantly
increased neural differentiation of mouse iPSCs
We then modified the approaches to initiate EB formation
and investigated whether neuronal differentiation efficiency of
mouse iPSCs could be enhanced. “Hanging drops” composed of
1000 dissociated cells in 20 μl of differentiating medium were
produced to generate EBs. No iPS cell line was found to increase
the neuronal differentiation in this method compared to the
previous one using the single-cell suspension EB formation
(Figs. 3B, b, C, c, D and E).
Interestingly, when we used the whole cell clones directly
isolated from feeder cells with a fire polished glass pipette to
initiate EB formation, neuronal differentiation of mouse iPSCs
was greatly improved (Figs. 3A and a). All iPS cell lines tested inthe study showed a remarkable enhancement in neuronal
differentiation as compared to the other two EB formation
approaches (Figs. 3D and E). Moreover, this approach improved
neuronal differentiation of some iPS cell lines to a level com-
parable to mouse ESCs (62% MAP2-positive cells and 52%
Islet1/2-positive cells in MEF-p differentiation, which are com-
parable to 67% MAP2-positive cells and 59% Islet1/2-positive
cells in R1 differentiation and 64% MAP2-positive cells and 57%
Islet1/2-positive cells in ES-C57BL/6 differentiation).
The whole cell clone-derived EB method also stimulated
more generation of iPSC-derived TH+ neurons. Following
the protocol described previously (Lee et al., 2000; Wernig
et al., 2008), mouse iPSCs were induced to differentiate
into dopaminergic neurons. As shown in Fig. S1, the whole
cell clone-derived EB method led to a nearly threefold
increase in TH+ cells generation in S5-3C5 differentiation
compared to the other two EB formation approaches
(35.6±2.7% of the Tuj1+ neurons in the whole cell clone-
derived EB method; 10.2±2.2% in the “hanging drops” EB
method; 9.6±1.5% in the single-cell suspension derived EB
method) and all tested iPS cell lines showed a significant
increase in the number of TH+ cells using the whole cell
clone-derived EB method.
We further compared the yield of neural stem cells among
these three EB methods. After 4 days RA treatment, EBs were
collected, and then dissociated to single cells by accutase and
Figure 2 Mouse iPSCs exhibit very low efficiency in neuronal differentiation using the single-cell suspension-derived EB method.
Schematic figure at the upper side showing EB formation from dissociated single cells in suspension. (A): MAP2 staining showing
efficient neuronal differentiation of ESCs (R1) after 5 days of treatment with RA and SHH. (a): Higher magnification of the area of
interest in A demonstrated that the majority of MAP2-positive neurons were co-expressing Islet1/2. (B): MAP2 staining showing
limited neuronal differentiation of iPSCs (IP14D-101) after 5 days of treatment with RA and SHH. (b): Higher magnification of the area
of interest in B. (C): All mouse iPS cell lines displayed a significantly lower efficiency in MAP2-positive cell differentiation compared
to mouse ESCs. (D): All mouse iPS cell lines displayed a significantly lower efficiency in Islet1/2-positive cell differentiation compared
to mouse ESCs. Data are shown as mean±SEM (n=5). *Pb0.001. Scale bar: 150 μm in A and B; 50 μm in a and b.
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dishes in N2B27 medium supplemented with 20ng/ml bFGF
and 20 ng/ml EGF. Primary neurospheres were formed after
5–7 days of culture. FACS analyses showed that the conven-
tional EB formation method, the single-cell suspension EB
method could induce a substantial proportion of NSCs in the
primary neurospheres derived from various iPS cell lines, which
ranged from 47% in TTF-1 differentiation to 58% in MEF-pdifferentiation (Fig. S2). The result is consistent with other
studies using the single-cell suspension EB method to success-
fully drive mouse iPSCs to generate neurospheres (Miura et al.,
2009; Tsuji et al., 2010). The “hanging drops” EB method
improved the percentage of NSCs in the primary neurospheres
compared to the single-cell suspension EBmethod, however, no
statistic difference in NSC yield of all tested iPS cell lines was
observed between the two methods (Fig. S2). Interestingly, the
Figure 3 Neuronal differentiation of mouse iPSCs can be significantly improved using the whole cell clone-derived EB method.
Schematic figures at the upper row showing EB formation from the whole cell clone, “hanging drops” and dissociated single cells in
suspension respectively. (A): MAP2 staining showing efficient neuronal differentiation of iPSCs (S5-3C5) using the whole cell
clone-derived EB method. (a): Higher magnification of the area of interest in A demonstrated that Islet1/2 was expressed on
differentiation to MAP2-positive neurons. (B): MAP2 staining showing limited neuronal differentiation of iPSCs (S5-3C5) using the
“hanging drops” EB method. (b): Higher magnification of the area of interest in B. (C): MAP2 staining showing limited neuronal
differentiation of iPSCs (S5-3C5) using the single-cell suspension-derived EB method. (c): Higher magnification of the area of interest
in C. (D): All iPS cell lines tested significantly increased the yield of MAP2-positive neurons using the whole cell clone-derived EB
method compared to using the “hanging drops” EB method and single-cell suspension-derived EB method (Pb0.001). (E): All iPS cell
lines tested significantly increased the yield of Islet1/2-positive neurons using the whole cell clone-derived EB method compared
to using the “hanging drops” EB method and single-cell suspension-derived EB method (Pb0.001). Data are shown as mean±SEM
(n=5). Scale bar: 150 μm in A, B and C; 50 μm in a, b and c.
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yield compared to the single-cell suspension EB method and
it produced the highest percentage of NSCs in iPSC-derived
primary neurospheres among the three methods (Fig. S2).The whole cell clone-derived EB method stimulated
the early activation of Cdh2 to promote neural
differentiation
We then explored the mechanisms underlying the potent
neural differentiation-promoting effect of the whole cell
clone EB method on driving mouse iPSCs to differentiate.
First, we carried out a GeneChip-based screen for candidate
genes activated in the initial phase of neural differentiation.Two mouse iPS cell lines (MEF-4 and MEF-p) were used and
total RNAs were extracted from their day 2 EBs initiated by 3
different methods in differentiating medium. Using the
multiple-sample comparison algorithm of expression pat-
terns, we identified 14 genes whose expression was high in
day 2 EBs of both cell lines initiated in the whole cell clone
EB method but low in both the single-cell suspension-derived
and the “hanging drops”-derived EBs (Fig. 4A). The cDNAs of
the candidate genes were then subcloned into retrovirus
vectors and overexpressed by infection in MEF-p cells. The
infected cells were subsequently induced to differentiate
using the single-cell suspension-derived EB method in which
we have shown that mouse iPSCs differentiate poorly into
neuronal cells (Fig. 3). However, among the 14 candidates,
one cloned MEF-p cells exhibited a high efficiency in neural
345Immediate expression of Cdh2 is essential for efficient neural differentiation of mouse iPSCsdifferentiation. This clone, Cdh2, also known as N-Cadherin,
encodes a classical cadherin from the cadherin superfamily
which functions during gastrulation and plays a critical role
in the developmental organization of the brain (Redies,
2000). Its expression was high in the whole cell clone-
derived day 2 EBs and low in the single-cell suspension-
derived and the “hanging drops”-derived day 2 EBs in both
MEF-p cells (Fig. 4B) and MEF-4 cells (data not shown).
However, no difference in Cdh2 expression was observed
between the day 2 EBs which were derived from the whole
cell clone and the single-cell suspension in mouse ESCs (R1).
The expression level of Cdh2 was high in all these mouse ESC
(R1 and ES-C57BL/6) EBs either from the whole cell clone or
from the single-cell suspension (data not shown). These
findings strongly indicate that Cdh2 plays a critical role in
controlling the neural differentiation efficiency mouse pluri-
poten cells. Forced expression of Cdh2 in mouse iPSCs sig-
nificantly increased the neuronal generation of the single-
cell suspension-derived EB method (Fig. 5C). FACS analyses
also showed that mouse iPSCs with forced expression of Cdh2
can substantially differentiate into NSCs in the adherent
monoculture method (Fig. 5D). These findings show that the
neural differentiation potency of iPSCs and the promoting
effect of the whole cell clone EB method are closely asso-
ciated with the early activation and up-regulated expression
of Cdh2.
We next investigated whether Cdh2 is required for the
neural differentiation of mouse iPSCs. The introduction of short
hairpin RNA (shCdh2#1 and shCdh2#2) targeting Cdh2 into R1
and MEF-p strongly suppressed the expression of Cdh2 (Figs. 6A
and C). Dissociated mouse ESCs (R1) in N2B27 medium could
efficiently differentiate into NSCs and formed abundant
rosette-like structures after plating in adherent mono-
culture (Fig. 6B). However, Cdh2-depleted R1 cells byFigure 4 GeneChip-based screen for candidate genes activated in
genes whose expression were high in the day 2 EBs of two iPS cell line
but low in both the single-cell suspension-derived and the “hanging
expression was high in the whole cell clone-derived day 2 EBs an
drops”-derived day 2 EBs in MEF-p cells.shCdh2#1 (Fig. 6B) or shCdh2#2 (data not shown) failed to
undergo neural differentiation with no rosette-like struc-
tures formed in adherent monoculture, which demonstrat-
ed that Cdh2 is indispensable for mouse ESCs to initiate
neural differentiation. Remarkably, Cdh2 shRNA pro-
nouncedly reduced the neural differentiation-promoting
effect of the whole cell clone EB method in MEF-p cells
(Fig. 6D) and MEF-4 cells (data not shown). Taken together
with the overexpression data, these observations showed
that early activation of Cdh2 underlies the potent neural
differentiation-promoting effect of the whole cell clone
EB method and is essential for mouse pluripotent cells to
undergo efficient neural differentiation.Survival and maturation of transplanted mouse iPSC
derivatives in vivo
The survival after transplanted cells in the host is an important
prerequisite of successful cell replacement strategies for the
treatment of neurodegenerative diseases such as motoneuron
diseases and Parkinson's disease. Therefore we investigated the
survival and integration of iPSC-derived motoneurons or dopa-
minergic neurons after transplanted in vivo. RFP-labeled iPSCs
(MEF-p) were induced into ChAT-positive neurons using the
whole cell clone-derived EB method and electrophysiological
analyses demonstrated that these iPSC-derived motoneurons
were physiologically functional (Fig. S3). When transplanted
into the transected sciatic nerve, iPSC-derived motoneu-
rons survived vigorously and extended axons along the nerve
(Fig. S3G). Grafted iPSC-derived dopaminergic neurons were
also found to survive substantially at 4 weeks after transplan-
tation into the striatum of adult mice (Fig. S4). These in vivo
findings indicate that iPSC-derived neuronal subtypes canthe initial phase of neural differentiation. (A): The heatmap of
s (MEF-4 and MEF-p) initiated in the whole cell clone EB method
drops”-derived EBs. (B): Real time PCR result showing that Cdh2
d low in the single-cell suspension-derived and the “hanging
Figure 5 Forced expression ofCdh2 inmouse iPSCs significantly increased the neuronal generation of the single-cell suspension-derived EB
method. (A): The features of pRLoxP-Puro retrovirus vectors containing Cdh2. (B): The introduction of Cdh2 gene into MEF-p strongly
increased the expression of Cdh2. (C): Forced expression of Cdh2 in mouse MEF-p cells significantly increased the motoneuron generation
(MAP2 and Islet1/2 staining) of the single-cell suspension-derived EB method. All mouse iPS cell lines with forced expression of Cdh2
significantly increased efficiency in MAP2-positive cell differentiation and Islet1/2-positive cell differentiation (Pb0.001). (D): FACS analyses
also showed that mouse iPSCs with forced expression of Cdh2 significantly increased the yield of Nestin-positive NSCs in the adherent
monoculture method (Pb0.001). Data are shown as mean±SEM (n=5). Scale bar: 50 μm in C.
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Figure 6 Cdh2 shRNA pronouncedly reduced the neural differentiation. The introduction of shRNA targeting Cdh2 into R1 (A) and
MEF-p (C) strongly suppressed the expression of Cdh2. (B): R1 could form abundant rosette-like structures and Cdh2-depleted R1 cells
failed to form rosette-like structures in the adherent monoculture. (D): Cdh2 shRNA pronouncedly reduced the neural
differentiation-promoting effect of the whole cell clone EB method in MEF-p. Scale bar: 50 μm in B and D.
347Immediate expression of Cdh2 is essential for efficient neural differentiation of mouse iPSCssurvive and mature after transplanted in vivo and have
therapeutic potential in cell replacement strategies for the
treatment of neuronal degenerative diseases.Discussion
Recent studies have reported that human iPSCs generate
neuroepithelia and functional neuronal subtypes with signifi-
cantly reduced efficiency and increased variability compared to
ESCs (Hu et al., 2010). Here, we reported that mouse iPSCs
failed to efficiently give rise to neuronal cells using conven-
tional methods previously established for driving mouse ESC
differentiation (Wichterle et al., 2002; Ying et al., 2003),
although mouse iPSCs are considered to be truly pluripotent
because they can produce viable mice through tetraploid
complementation (Boland et al., 2009; Zhao et al., 2009).
Previous studies reported that mouse iPSCs could generate
various types of neural cells (Castiglioni et al., 2012; Tsuji et al.,
2010; Wernig et al., 2008). However, all these studies did not
specify the efficiency of neural differentiation of mouse iPSCs
when they were induced to differentiate. A number of studies
suggest that there is existence of an intrinsic difference in gene
expression between iPSCs and ESCs (Gore et al., 2011; Hussein
et al., 2011; Lister et al., 2011; Mayshar et al., 2010; Stadtfeld
et al., 2010), which may account for the difference of theirdifferentiation propensity. A very interesting finding in the
present study is that the differentiation efficiency of mouse
iPSCs can be improved by modulating the EB formation. All iPS
cell lines tested in the study showed a remarkable enhancement
in neural differentiation using the whole cell clone-derived EB
method in that some iPS cell lines improved the differentiation
efficiency to a level comparable to ESCs.
The difference in neural differentiation potential among the
three EB methods enables us to dig out the critical regulators
which control mouse iPSCs to differentiate. We found that EBs
initiated from the whole cell clones expressed much higher
levels of Cdh2 than those from aggregating by dissociated single
cells. The whole cell clone-derived EB method preserves the
microenvironment of iPSCs, especially the cell–cell interaction
between one and another, which possibly facilitates to trigger
the activation of Cdh2. Cdh2 plays an important role in regu-
lating nervous system development by providing key molecular
cues in many biological processes across species (Lele et al.,
2002; Miyatani et al., 1989; Radice et al., 1997) and is essential
for maintaining the normal architecture of neuroepithelial cells
during brain development (Kadowaki et al., 2007). It has been
reported that precursor cell interactions can activate Cdh2
expression and generate a self-supportive niche to regulate
their own number and cell fate (Zhang et al., 2010). Gene
screening analyses, forced expression and knockdown studies
suggest that the early activation of Cdh2 underlies the potent
348 H. Su et al.neural differentiation-promoting effect of the whole cell clone
EB method and is essential for mouse iPSCs to undergo efficient
neural differentiation.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.01.003.
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